Amalgamated Bank Syndax Pharmaceuticals Inc Transaction History
Amalgamated Bank
- $12.2 Billion
- Q4 2024
A detailed history of Amalgamated Bank transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 2,766 shares of SNDX stock, worth $41,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,766
Previous 2,766
-0.0%
Holding current value
$41,268
Previous $53,000
30.19%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SNDX
# of Institutions
227Shares Held
95.1MCall Options Held
759KPut Options Held
635K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$127 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$118 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$88.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$79.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$72.8 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $844M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...